World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
27499
World Ranking
2272
National Ranking
1101

Medicine

D-Index
71
Citations
27499
World Ranking
19936
National Ranking
9928

Overview

Mark B. Feinberg is affiliated with the International AIDS Vaccine Initiative in the United States. Their research primarily focuses on medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. A significant portion of their work falls under the subfields of infectious diseases, molecular biology, immunology, virology, and genetics.

The scientist's main topics of research include:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Viral Infections and Outbreaks Research
  • Virus-based gene therapy research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Immunotherapy and Immune Responses

Their recent papers reflect a focus on vaccine development, immunogenicity, and antibody production related to COVID-19 and HIV. Notable publications include:

  • "A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates," 2023, Nature Communications
  • "Rapid cGMP manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools," 2021, Biotechnology and Bioengineering
  • "Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera," 2022, EBioMedicine
  • "Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth," 2020, Vaccines
  • "A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates," 2022, bioRxiv (Cold Spring Harbor Laboratory)

The scientist's frequent coauthors include Payton A. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, and Prabhu S. Arunachalam. These collaborations have contributed to multiple publications across various respected venues.

Publication venues that frequently feature the scientist's work include Nature Communications, EBioMedicine, bioRxiv (Cold Spring Harbor Laboratory), Vaccines, and Biotechnology and Bioengineering.

Best Publications

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

    A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith

  • Changes in thymic function with age and during the treatment of HIV infection

    Daniel C. Douek;Richard D. McFarland;Phillip H. Keiser;Earl A. Gage

  • The trans-activator gene of HTLV-III is essential for virus replication

    Fisher Ag;Feinberg Mb;Josephs Sf;Harper Me

  • Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

    Joseph M. McCune;Linda B. Rabin;Mark B. Feinberg;Miriam Lieberman

  • HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA

    Mark B. Feinberg;Ruth F. Jarrett;Anna Aldovini;Robert C. Gallo

  • Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

    Guido Silvestri;Donald L. Sodora;Richard A. Koup;Richard A. Koup;Mirko Paiardini

  • Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

    Jeffrey D. Lifson;Jeffrey D. Lifson;Mark B. Feinberg;Gregory R. Reyes;Linda Rabin

  • The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

    M D Miller;M T Warmerdam;I Gaston;W C Greene

  • Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.

    Joseph D. Miller;Robbert G. van der Most;Rama S. Akondy;John T. Glidewell

  • Regulation of the human interleukin-2 receptor α chain promoter: Activation of a nonfunctional promoter by the transactivator gene of HTLV-I

    Sharon L Cross;Mark B Feinberg;Julie B Wolf;Nikki J Holbrook

  • Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I

    M Siekevitz;M B Feinberg;N Holbrook;F Wong-Staal

  • Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

    Roger J. Pomerantz;Roger J. Pomerantz;Didier Trono;Mark B. Feinberg;David Baltimore

  • The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation.

    Mark B. Feinberg;David Baltimore;Alan D. Frankel

  • Multiple sclerosis and human T-cell lymphotropic retroviruses.

    Hilary Koprowski;Elaine C. DeFreitas;Mary E. Harper;Magnhild Sandberg-Wollheim

  • Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

    T Harrer;E Harrer;S A Kalams;P Barbosa

  • HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus

    Didier Trono;Mark B. Feinberg;David Baltimore

  • Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections

    Judith N Mandl;Ashley P Barry;Thomas H Vanderford;Natalia Kozyr

  • Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type 1 Infection

    Thomas Harrer;Ellen Harrer;Spyros A. Kalams;Tarek Elbeik

  • ACTIVATION OF VIRUS REPLICATION AFTER VACCINATION OF HIV-1-INFECTED INDIVIDUALS

    S I Staprans;B L Hamilton;S E Follansbee;T Elbeik

  • AIDS vaccine models: challenging challenge viruses.

    Mark B Feinberg;John P Moore

Frequent Co-Authors

Guido Silvestri
Guido Silvestri Emory University
Raul Andino
Raul Andino University of California, San Francisco
David Baltimore
David Baltimore California Institute of Technology
Silvija I. Staprans
Silvija I. Staprans Bill & Melinda Gates Foundation
Ann Chahroudi
Ann Chahroudi Emory University
Flossie Wong-Staal
Flossie Wong-Staal University of California, San Diego
Bruce D. Walker
Bruce D. Walker Harvard University
Robert C. Gallo
Robert C. Gallo University of South Florida
Warner C. Greene
Warner C. Greene University of California, San Francisco
John D. Altman
John D. Altman Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA can open doors to various online degree programs and career pathways, especially within healthcare and nursing fields. For those interested in advancing clinical expertise, exploring dnp salary by specialty can help identify the financial benefits tied to different areas of nursing practice, including immunology-related roles.

Nurses aiming to specialize further might consider transitioning certifications, such as moving from a Family Nurse Practitioner to an acute care setting. The insights found in fnp to acute care certification highlight key steps and requirements for this path, which complements immunology-focused patient care in acute or critical settings.

Accelerated options are also available for busy professionals. Those looking for fast-tracked education may benefit from accelerated np programs online, which help candidates quickly gain advanced credentials necessary for immunology-related advanced practice roles.

For newcomers without nursing backgrounds, foundational programs like the best online bsn programs for non nurses offer accessible routes to enter the field, creating pathways toward immunology and related healthcare careers.

Best Scientists Citing Mark B. Feinberg

Trending Scientists